Search results

From WikiLectures

  • ATC code L is a section of the Anatomical-Therapeutic-Chemical Classification of Medicines . L01 - Cytostatics L02 - Endocrine therapy L03 - Immunomodulating
    538 bytes (39 words) - 22:30, 31 May 2023
  • Rituximab (trade names Rituxan, MabThera and Zytux, ATC L01XC02) is a chimeric monoclonal antibody directed against CD20 , a surface antigen of primarily
    416 bytes (46 words) - 17:02, 7 January 2023
  • can be classified according to various aspects, classification according to ATC and rough classification into indication groups are common. The chemical name
    8 KB (579 words) - 20:26, 31 May 2023
  • Pause 10% or 0.2-0.4sec. PEEP base 5cm H2O. Trigger −0.5 to −1 cm H20 or 3–5 l/min. FiO2 0.4; depending on the situation. Transpulmonary pressure up to 35
    13 KB (1,646 words) - 16:26, 20 January 2024
  • Trial (SBT) - Spontaneous breathing on low pressure support (5-7 cm H 2 O)/ATC or Ayer 'T' at FiO 2 0.5. Closer monitoring is needed for the first few minutes
    9 KB (1,020 words) - 16:23, 19 November 2022
  • Pause 10% or 0.2-0.4sec . PEEP base 5cm H2O. Trigger −0.5 to −1 cm H20 or 3–5 L/min. FiO2 0.4 ; depending on the situation. Transpulmonary pressure up to 35
    13 KB (1,645 words) - 18:27, 25 April 2024